onr:"swepub:oai:DiVA.org:liu-106838"
Search: onr:"swepub:oai:DiVA.org:liu-106838" > Pharmacogenetic asp...
- 1 of 1
- Previous record
- Next record
- To hitlist
Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose
-
- Bastami, Salumeh (author)
- Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet
-
- Haage, Pernilla (author)
- Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,National Board of Forensic Medicine, Department of Forensic Genetics and Forensic Toxicology, Linköping, Sweden
-
- Kronstrand, Robert (author)
- Linköpings universitet,Avdelningen för läkemedelsforskning,Hälsouniversitetet,National Board of Forensic Medicine, Department of Forensic Genetics and Forensic Toxicology, Linköping, Sweden
- show more...
- show less...
- (creator_code:org_t)
- Elsevier, 2014
- 2014
- English.
- In: Forensic Science International. - : Elsevier. - 0379-0738 .- 1872-6283. ; 238, s. 125-132
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- The major purpose of this study was to elucidate if genotyping can facilitate interpretations of tramadol (TRA) in forensic case work, with special regard to the estimation of the time of drug intake and drug related symptoms (DRS). The association between genetic polymorphisms in CYP2D6, OPRM1 and ABCB1 and pharmacokinetic and pharmacodynamic properties of TRA was studied. Nineteen healthy volunteers were randomized into two groups receiving a single dose of either 50 or 100 mg of orally administrated TRA. Blood samples were collected prior to dosing and up to 72 h after drug intake. The subjects were asked to report DRS during the experimental day. We found a positive correlation between the metabolic ratio of O-desmethyltramadol (ODT) to TRA and the time after drug intake for both CYP2D6 intermediate metabolizers and extensive metabolizers. For the only poor metabolizer with detectable ODT levels the metabolic ratio was almost constant. Significant associations were found between the area under the concentration-time curve (AUC) and three of the investigated ABCB1 single nucleotide polymorphisms for TRA, but not for ODT and only in the 50 mg dosage group. There was great interindividual variation in DRS, some subjects exhibited no symptoms at all whereas one subject both fainted and vomited after a single therapeutic dose. However, no associations could be found between DRS and investigated polymorphisms. We conclude that the metabolic ratio of ODT/TRA may be used for estimation of the time of drug intake, but only when the CYP2D6 genotype is known and taken into consideration. The influence of genetic polymorphisms in ABCB1 and OPRM1 requires further study.
Keyword
- Tramadol; Pharmacokinetics; Pharmacodynamics; CYP2D6; ABCB1; OPRM1
- MEDICINE
- MEDICIN
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Forensic Science International (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Bastami, Salumeh
- Haage, Pernilla
- Kronstrand, Robe ...
- Kugelberg, Fredr ...
- Zackrisson, Anna ...
- Uppugunduri, Sri ...
- Articles in the publication
- Forensic Science ...
- By the university
- Linköping University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
